Oral Minoxidil Cannabis Interaction Profile: What Patients and Clinicians Need to Know
At a glance
- Interaction status / Not a labeled interaction; guanethidine is the only one the oral label names [1]
- Minoxidil mechanism / Direct-acting peripheral arteriolar vasodilator [1]
- Orthostatic hypotension / Label says minoxidil does not itself cause it [1]
- Low-dose blood pressure / No significant systolic or diastolic change at 5 mg/day or less; heart rate +2.67 beats/min [3]
- Common low-dose effects / Lightheadedness 1.7%, fluid retention 1.3%, tachycardia 0.9% [4]
- Cannabis note / Cannabinoids can affect drug-metabolizing enzymes, with few specific data [5]
What does the label say about minoxidil's cardiovascular effects?
Oral minoxidil is a direct-acting peripheral arteriolar vasodilator that lowers blood pressure by decreasing peripheral vascular resistance [1]. The fall in pressure triggers reflex increases in heart rate, cardiac output, renin, and salt and water retention; the label says a beta blocker is usually needed to prevent tachycardia and increased myocardial workload, and a diuretic to prevent serious fluid accumulation [1]. The label says minoxidil does not interfere with vasomotor reflexes and therefore does not produce orthostatic hypotension, but that profound orthostatic hypotension can occur when it is given to patients already receiving guanethidine [1]. At antihypertensive doses, the boxed warning covers pericardial effusion, occasionally progressing to tamponade, and worsening angina [1].At hair-loss doses, what is known?
Low-dose oral minoxidil for hair loss is off-label; the tablet label says use to promote hair growth is not an approved indication [1]. A 2025 meta-analysis of oral minoxidil at 5 mg/day or less found no significant change in systolic blood pressure (mean difference -0.13 mm Hg; 95% CI -2.67 to 2.41) or diastolic blood pressure (-1.25 mm Hg; 95% CI -3.21 to 0.71), but a significant heart-rate increase of 2.67 beats/min (95% CI 0.34 to 5.01) [3]. Hypotensive symptoms were reported in 119 patients (5.0%), and no hypotensive episodes were observed [3]. In a 1,404-patient retrospective study, lightheadedness occurred in 1.7%, fluid retention in 1.3%, tachycardia in 0.9%, and systemic effects led to discontinuation in 1.2%; there was no control group [4].Could cannabis change minoxidil levels?
Oral minoxidil is about 90% metabolized, mainly by glucuronide conjugation; the label does not name a CYP enzyme for its metabolism [1]. A review of medicinal cannabis interactions says cannabinoids can affect cytochrome P450 and UDP-glucuronosyltransferases, but few data exist for specific combinations [5]. The American Heart Association statement reviews cannabis and cardiovascular health in general, and notes that understanding of cannabis has been limited by decades of worldwide illegality and its Schedule 1 classification in the United States [2].Frequently asked questions
Is oral minoxidil with cannabis a known interaction?
The only drug interaction the oral minoxidil label names is guanethidine, which can cause profound orthostatic hypotension [1]. Cannabis is not listed.
Does oral minoxidil lower blood pressure?
Yes. Oral minoxidil lowers blood pressure and is approved only for severe hypertension [1]. In studies of 5 mg/day or less for hair loss, average systolic and diastolic blood pressure did not change significantly, but heart rate rose by 2.67 beats/min and 5.0% of patients reported hypotensive symptoms, with no hypotensive episodes observed [3].
Can cannabis affect how minoxidil is cleared?
Minoxidil is mainly cleared by glucuronide conjugation, and its label does not name a CYP enzyme [1]. A review of medicinal cannabis interactions says cannabinoids can affect cytochrome P450 and UDP-glucuronosyltransferases, but few data exist for specific drugs [5].
Is the risk different at hair-loss doses versus blood-pressure doses?
Oral minoxidil is not FDA-approved for hair loss; the label says use to promote hair growth is not an approved indication [1]. The label's usual effective antihypertensive range is 10 to 40 mg/day [1], while the low-dose meta-analysis covered 5 mg/day or less [3]. The boxed warning is written for antihypertensive doses [1].
References
- U.S. National Library of Medicine, DailyMed. Minoxidil tablets (oral), Par Health prescribing information. Minoxidil tablets (oral), Par Health label
- Page RL, Allen LA, Kloner RA, Carriker CR, Martel C, Morris AA, et al. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2020;142(10):e131-e152. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association
- Chen M, Weichert M, Guo W, Ruzic R, Briley J. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis. J Am Acad Dermatol. 2025;92(3):554-555. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Alsherbiny MA, Li CG. Medicinal Cannabis-Potential Drug Interactions. Medicines (Basel). 2018;6(1). Medicinal Cannabis-Potential Drug Interactions